Dr. Lal PathLabs Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
3,055.10 -35.65 (-1.15%)Updated : 11 Nov 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 1,902.101,758.491,677.241,632.88
Other Net 5.511.29-0.330.60
Diluted Weighted Average Shares 8.348.328.318.29
Gain( Loss)on Saleof Assets -2.15-0.220.81-0.60
Depreciation/ Amortization 141.58143.34150.19108.11
Operating Income 559.30468.15339.64454.53
Net Income 487.14357.74238.85344.83
Income Availableto Com Excl Extra Ord 487.14357.74238.85344.83
Other Operating Expenses Total 31.3541.9337.0837.81
Net Income Before Taxes 624.80505.45343.83474.98
Minority Interest -5.11-4.56-2.23-5.46
Interest Exp( Inc) Net- Operating Total 0.350.26--
Net Income After Taxes 492.25362.29241.08350.29
Income Availableto Com Incl Extra Ord 487.14357.74238.85344.83
Costof Revenue Total 508.62477.59473.06524.37
Gross Profit 1,952.771,749.051,543.821,563.04
Interest Inc( Exp) Net- Non- Op Total 62.1536.233.7120.45
Diluted Net Income 487.14357.74238.85344.83
DPS- Common Stock Primary Issue 24.0024.0012.0012.00
Provisionfor Income Taxes 132.55143.16102.75124.69
period Type ----
Net Income Before Extra Items 487.14357.74238.85344.83
Total Revenue 2,461.402,226.642,016.882,087.41
period Length 12.0012.0012.0012.00
Revenue 2,461.402,226.642,016.882,087.41
Selling/ General/ Admin Expenses Total 1,220.201,095.381,016.91962.59
Diluted Normalized EPS 58.6043.0028.6741.63
Diluted EPS Excluding Extra Ord Items 58.4042.9828.7441.57
Dilution Adjustment ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,009.80-75.60 (-6.97%)
1,994.00-126.45 (-5.96%)